# MiR-146b overexpression promotes bladder cancer cell growth via the SMAD4/C-MYC/Cyclin D1 axis

**Authors:** Junlan Zhu, Zhijian Zheng, Zhangya Yin, Linchao Ding, Congya Li, Xuyao Wang, Peng Shu, Jun Zhou, Weihua Liu, Jian Liu

PMC · DOI: 10.3389/fonc.2025.1565638 · Frontiers in Oncology · 2025-03-28

## TL;DR

MiR-146b promotes bladder cancer growth by regulating a pathway involving SMAD4, C-MYC, and Cyclin D1, offering a potential target for treatment.

## Contribution

The study identifies a novel regulatory axis (SMAD4/C-MYC/Cyclin D1) through which miR-146b promotes bladder cancer cell proliferation.

## Key findings

- Downregulation of miR-146b suppresses bladder cancer cell growth by inducing G0/G1 cell cycle arrest.
- MiR-146b reduces SMAD4 mRNA stability, leading to increased C-MYC and Cyclin D1 expression, which promotes cancer cell proliferation.

## Abstract

MiR-146b has been identified as being overexpressed in human bladder cancer (BCa) and implicated in promoting cancer cell invasion. However, its specific involvement in BCa cell growth remains unclear. In this study, we demonstrate that the downregulation of miR-146b significantly suppresses tumorigenic growth of human BCa cells both in vitro and in vivo by inducing G0/G1 cell cycle arrest. Specifically, miR-146b inhibition resulted in a significant reduction in colony formation (p < 0.05) and anchorage-independent growth in both UMUC3 and T24T cells, as measured by soft agar assays, with three independent replicates for each experiment. Notably, Cyclin D1 protein plays a crucial role in miR-146b-induced BCa cell proliferation, as confirmed by Western blotting (p < 0.05), with each experiment performed in triplicate. Mechanistic investigations reveal that miR-146b reduces mothers against decapentaplegic homolog 4 (SMAD4) mRNA stability by directly binding to its 3′ untranslated region (3′-UTR), leading to decreased SMAD4 expression. This reduction in SMAD4 levels promotes cellular myelocytomatosis (C-MYC) transcription, which in turn enhances Cyclin D1 transcription, ultimately facilitating BCa cell proliferation. The findings unveil a novel regulatory axis involving SMAD4/C-MYC/Cyclin D1 in mediating the oncogenic role of miR-146b in BCa cells. Statistical significance was determined using Student’s t-test, with p-values <0.05 considered significant. Together with its previously established function in BCa invasion, the results highlight the potential for developing miR-146b-based therapeutic strategies for treating human BCa patients.

## Linked entities

- **Genes:** MIR146B (microRNA 146b) [NCBI Gene 574447], SMAD4 (SMAD family member 4) [NCBI Gene 4089], MYC (MYC proto-oncogene, bHLH transcription factor) [NCBI Gene 4609], ccnd1.S (cyclin D1 S homeolog) [NCBI Gene 379161]
- **Diseases:** bladder cancer (MONDO:0004986)

## Full-text entities

- **Genes:** CCND1 (cyclin D1) [NCBI Gene 595] {aka BCL1, D11S287E, PRAD1, U21B31}, SMAD4 (SMAD family member 4) [NCBI Gene 4089] {aka DPC4, JIP, MADH4, MYHRS}, MIR146B (microRNA 146b) [NCBI Gene 574447] {aka MIRN146B, miRNA146B, mir-146b}
- **Diseases:** C-MYC (MESH:D004806), cancer (MESH:D009369), tumorigenic (MESH:D002471), BCa (MESH:D001749)
- **Chemicals:** agar (MESH:D000362)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** BCa — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_S780), T24T — Homo sapiens (Human), Bladder carcinoma, Cancer cell line (CVCL_M892), UMUC3 — Homo sapiens (Human), Bladder carcinoma, Cancer cell line (CVCL_1783)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11985428/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11985428/full.md

## References

47 references — full list in the complete paper: https://tomesphere.com/paper/PMC11985428/full.md

---
Source: https://tomesphere.com/paper/PMC11985428